SAFETY OF CONCURRENT ADMINISTRATION OF OZANIMOD AND SEROTONERGIC ANTIDEPRESSANTS IN PATIENTS WITH ULCERATIVE COLITIS

Jean-Frédéric Colombel  ¹     Lorna Charles  ²     AnnKatrin Petersen  ²     Michael Silver  ²     James K. Sheffield  ²     Neil Minton  ²     Marc Gleichmann  ²     Hongjuan Liu  ²     Jon Riolo  ²     Diego Silva  ²     Robert T. Naismith  ³     Bruce A. C. Cree  ⁴     Miguel Regueiro  ^5    
1 Icahn School of Medicine at Mount Sinai, New York, United States
² Bristol Myers Squibb Company, Princeton, United States
³ Washington University School of Medicine, St Louis, United States
⁴ Weill Institute for Neurosciences, University of California San Francisco, San Francisco, United States
⁵ Cleveland Clinic, Cleveland, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)